Stanford pathologist speaks to the likelihood of undetectable COVID-19 and best practices for staying safe in the face of uncertainty.
Category: Infectious disease
Molecular makeover makes wimpy antibody a SARS-CoV-2 tackler
By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.
Monkeypox: What does sex have to do with it?
A Stanford infectious disease expert explains why a recent case of monkeypox transmission at a crowded festival isn’t cause for alarm.
Antibiotics might not be the best answer for C. diff
A new testing tool helps doctors avoid unnecessary antibiotic treatment in patients with diarrhea and suspected C. diff infection.
Stanford Medicine magazine explores the molecules within us
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Preparing for the viruses we’ve yet to meet
Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.
Tackling typhoid, one finger prick at a time
Stanford infectious disease experts devise a way to use finger-prick blood samples from small groups to detect typhoid in large populations.
A new approach to vaccinations: 3D printed patches
Researchers have created a new prototype technology to administer vaccines: a 3D printed patch that packs a punch.
Physician explains how COVID-19 mutes sense of smell
Physician-scientist weighs in on how the virus behind COVID-19 hampers your sense of smell and, sometimes, taste.
Endemic: What it might mean for masks, COVID-19 shots and more
Stanford experts discuss what ‘endemic’ means in the context of biology, masking, vaccines, and mental and behavioral health.
Fighting childhood infectious disease, lessons from COVID-19
Stanford Medicine pediatric infectious disease researcher describes her work in childhood infectious disease and lessons from the pandemic.
Vaccines provide broad protection against COVID-19, scientists say
According to a Stanford study, vaccines against COVID-19 are better than infection at generating antibodies to recognize new viral variants.
Protecting at-risk patients by tracking COVID-19 antibodies
According to a study, antibodies circulating after SARS-CoV-2 vaccinations wane rapidly in people who are receiving dialysis.
Pandemic Puzzle: Vaccinating children
A Stanford Medicine researcher discusses COVID-19 vaccination for children and why it's important for them to get the shot.
Why are smokers at an increased risk for severe COVID-19?
Tobacco smoke blocks airway cells from making a protein that protects against infection by the virus that causes COVID-19.
Can marketing strategies help increase vaccination rates?
Researchers at Stanford are exploring using traditional marketing strategies to help increase COVID-19 vaccine acceptance.